Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model

Journal of Inflammation (United Kingdom)

Volumn 10, Issue 1, 2013, Pages

  Song, Jingchun ^a,b   Hu, Dunzhong ^a   He, Chao ^a   Wang, Tao ^a   Liu, Xuefeng ^a   Ma, Linhao ^a   Lin, Zhaofen ^a   Chen, Zili ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 94th Hospital of PLA   (China)

Author keywords

Cecal ligation and puncture; Disseminated intravascular coagulation; Mouse; Platelet derived factor; Protein microarray

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOTIN; CHEMOKINE; D DIMER; FIBRINOGEN; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN; THYMUS CHEMOKINE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CECUM; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVITY; FIBRINOGEN BLOOD LEVEL; HISTOLOGY; LIGATION; LUNG; MALE; MESENTERY; MICROTHROMBUS; MORTALITY; MOUSE; NONHUMAN; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTHROMBIN TIME; PUNCTURE; SEPSIS; SURVIVAL; THROMBOCYTE COUNT;

MUS;

EID: 84874462879     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-10-7     Document Type: Article

References (45)

1. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR, Crit Care Med 2001 29 7 1303 1310 10.1097/00003246-200107000-00002 11445675
2. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Jesús B, Arturo M-B, Víctor S, Francisco T, Francisco G, Luís T, Javier C, Ángel G-L, Demetrio C, Manuel V, Martín De F, María-Jesús L, Ana C, José G, Braulio Á Agustín M, Jesús V, Crit Care 2008 12 158 10.1186/cc7157 19091069
3. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, Intensive Care Med 2008 34 1 17 60 10.1007/s00134-007-0934-2 18058085
4. Sepsis: definition, epidemiology, and diagnosis. Lever A, Mackenzie I, BMJ 2007 335 7625 879 883 10.1136/bmj.39346.495880.AE 17962288
5. Harmful molecular mechanisms in sepsis. Rittirsch D, Flierl MA, Ward PA, Nat Rev Immunol 2008 8 10 776 787 10.1038/nri2402 18802444
6. Disseminated intravascular coagulation in sepsis. Zeerleder S, Hack CE, Wuillemin WA, Chest 2005 128 4 2864 2875 10.1378/chest.128.4.2864 16236964
7. The coagulant response in sepsis. Levi M, Clin Chest Med. 2008 29 4 627 642 10.1016/j.ccm.2008.06.006 18954698
8. Animal models of DIC and their relevance to human DIC: a systematic review. Berthelsen LO, Kristensen AT, Tranholm M, Thromb Res 2011 128 2 103 116 10.1016/j.thromres.2010.12.002 21215993
9. Wuillemin. Disseminated intravascular coagulation in sepsis. Sacha Zeerleder C, Erik H, Walter A, Chest 2005 128 2864 2875 10.1378/chest.128.4.2864 16236964
10. Coagulation in sepsis. Amaral A, Opal SM, Vincent JL, Intensive Care Med 2004 30 6 1032 1040 10.1007/s00134-004-2291-8 15148567
11. Disseminated intravascular coagulation in infectious disease. Levi M, Schultz M, van der Poll T, Semin Thromb Hemost 2010 36 4 367 377 10.1055/s-0030-1254046 20614389
12. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Kitchens CS, Hematology Am Soc Hematol Educ Program 2009 2009 240 246 10.1182/asheducation-2009.1.240
13. Does disseminated intravascular coagulation lead to multiple organ failure? Vincent JL, De Backer D, Crit Care Clin 2005 21 3 469 477 10.1016/j.ccc.2005.04.002 15992668
14. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Thromb Haemost 2001 86 1327 1330 11816725
15. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, Fiedler F, Borggrefe M, Thromb Haemost 2004 91 812 818 15045145
16. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. Dhainaut JF, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP, Levi M, J Thromb Haemost 2004 2 1924 1933 10.1111/j.1538-7836.2004.00955.x 15550023
17. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay. Gris JC, Faillie JL, Cochery-Nouvellon E, Lissalde-Lavigne G, Lefrant JY, J Thromb Haemost 2011 9 6 1252 1255 10.1111/j.1538-7836.2011.04270.x 21645228
18. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Crit Care Med 2006 34 625 631 16521260
19. Coagulopathy of sepsis. Dempfle CE, Thromb Haemost 2004 91 2 213 224 14961146
20. Coagulation biomarkers in critically ill patients. Levi M, Schultz M, van der Poll T, Crit Care Clin 2011 27 2 281 297 10.1016/j.ccc.2010.12.009 21440202
21. Etiopathophysiology of disseminated intravascular coagulation. Bakhshi S, Arya LS, J Assoc Physicians India 2003 51 796 800 14651143
22. Blood coagulation disorders in septic patients. Knoebl P, Wien Med Wochenschr 2010 160 5-6 129 138 20364416
23. Augmentation of platelet and endothelial cell eNOS activity decreases sepsis-related neutrophil-endothelial cell interactions. Khan R, Kirschenbaum LA, LaRow C, Berna G, Griffin K, Astiz ME, Shock 2010 33 3 242 246 10.1097/SHK.0b013e3181b0f96f 19536045
24. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. Cox D, Kerrigan SW, Watson SP, J Thromb Haemost 2011 9 6 1097 1107 10.1111/j.1538-7836.2011.04264.x 21435167
25. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. Ma AC, Kubes P, J Thromb Haemost 2008 6 3 415 420 10.1111/j.1538-7836. 2007.02865.x 18088344
26. Immunodesign of experimental sepsis by cecal ligation and puncture. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA, Nat Protoc 2009 4 1 31 36 19131954
27. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. King J, Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Am J Respir Crit Care Med 1995 151 302 309 10.1164/ajrccm.151.2.7531097 7531097
28. Minna JD, Robby SH, Colman RW, Disseminated Intravascular Coagulation in Man Springfield, IL: Charles C. Thomas 1974
29. Platelet alpha-granules: basic biology and clinical correlates. Blair P, Flaumenhaft R, Blood Rev 2009 23 4 177 189 10.1016/j.blre.2009.04.001 19450911
30. The role of microparticles in inflammation and thrombosis. Ardoin SP, Shanahan JC, Pisetsky DS, Scand J Immunol 2007 66 2-3 159 165 17635793
31. Protein microarrays and proteomics. MacBeath G, Nat Genet 2002 32 526 S532 10.1038/ng1037
32. Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Kim HB, Kim CK, Iijima K, Kobayashi T, Kita H, Chest 2009 135 2 295 302 10.1378/chest.08-0962 19017877
33. Sepsis and septic shock-a review of laboratory models and a proposal. Wichterman KA, Baue AE, Chaudry IH, J Surg Res 1980 29 2 189 201 10.1016/0022-4804(80)90037-2 6997619
34. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock. Wang Z, Su F, Rogiers P, Crit Care Med 2007 35 11 2594 2600 10.1097/01.CCM.0000287590.55294.40 17901839
35. Antithrombin III pretreatment reduces neutrophil recruitment into the lung in a rat model of abdominal sepsis. Koca U, Olguner C, Ozkardeşler S, Karci A, Coker C, Tuncel P, Taşdöĝen A, Duru S, Ulukuş C, Elar Z, Acta Anaesthesiol Scand 2005 49 2 203 208 10.1111/j.1399-6576.2004.00567.x 15715622
36. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats. Inoue Y, Kohno S, Miyazaki T, Yamaguchi K, Tohoku J Exp Med 1991 163 3 175 185 10.1620/tjem.163.175 2063402
37. Animal models of sepsis and shock: a review and lessons learned. Deitch EA, Shock 1998 9 1 1 11 10.1097/00024382-199801000-00001 9734290
38. Leucocyte typing V: White cell differ entiation antigens Oxford: Oxford University Press, Schlossmann SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, 1995
39. A platelet alpha- granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. Stenberg PE, McEven RP, Shuman MA, Jacques YV, Bainton DF, J Cell Biol 1985 101 880 886 10.1083/jcb.101.3.880 2411738
40. The origin of p-selectin as a circulating protein. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK, Thromb Haemost 1997 77 1081 1085 9241736
41. A thrombin-sensitive protein of human platelet membranes. Baenziger NL, Brodie GN, Majerus PW, Proc Natl Acad Sci U S A 1971 68 1 240 243 10.1073/pnas.68.1.240 5276296
42. Thrombospondin-1: multiple paths to inflammation. Lopez-Dee Z, Pidcock K, Gutierrez LS, Mediators Inflamm 2011 2011 296069 21765615
43. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation. Matsuo T, Matsuo M, Sugimoto T, Wanaka K, Pathophysiol Haemost Thromb 2007 36 6 305 310 10.1159/000296281 20224256
44. Divergent associations of tissue inhibitors of metalloproteinases-1 and -2 with the prothrombotic/fibrinolytic state. Aznaouridis K, Vlachopoulos C, Dima I, Vasiliadou C, Ioakeimidis N, Baou K, Stefanadi E, Stefanadis C, Atherosclerosis 2007 195 1 212 215 10.1016/j.atherosclerosis.2006.12.015 17222415
45. Chemokines. a new classification system and their role in immunity. Zlotnik A, Yoshie O, Immunity 2000 12 2 121 127 10.1016/S1074-7613(00)80165-X 10714678